Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 208-214 , March 2010

Symmetric corticobasal degeneration (S-CBD)

  • Anhar Hassan

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
    • ,
  • Jennifer L. Whitwell

      Affiliations

    • Department of Radiology Research, Mayo Clinic, Rochester, MN, USA
    • ,
  • Bradley F. Boeve

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
    • ,
  • Clifford R. Jack Jr.

      Affiliations

    • Department of Radiology Research, Mayo Clinic, Rochester, MN, USA
    • ,
  • Joseph E. Parisi

      Affiliations

    • Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    • ,
  • Dennis W. Dickson

      Affiliations

    • Departments of Neuroscience (Neuropathology), Mayo Clinic, Jacksonville, FL, USA
    • ,
  • Keith A. Josephs

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 507 538 1038; fax: +1 507 538 6012.

Received 26 August 2009 ,Revised 23 November 2009 ,Accepted 25 November 2009.

References 

  1. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Houropian D, Ikeda K, et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neuro. 2002;61:935–946
  2. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18:20–33
  3. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54:S15–S19
  4. Pillon B, Blin J, Viadailet M, Deweer B, Sirigu A, Dubois B, et al. The neuropsychological pattern of corticobasal degeneration. Neurology. 1995;45:1477–1483
  5. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortico-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology. 1996;46:720–726
  6. Josephs KA, Tang-Wai DF, Edland SD, Knopman DS, Dickson DW, Parisi JE, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol. 2004;61:1881–1884
  7. Huang KJ, Lu MK, Kao A, Tsai CH. Clinical, imaging and electrophysiological studies of corticobasal degeneration. Acta Neurol Taiwanica. 2007;16:13–21
  8. Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, Mizutani T. Imaging of corticobasal degeneration syndrome. Neuroradiology. 2007;49:905–912
  9. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63:81–86
  10. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66:41–48
  11. Boeve BF. Links between frontotemporal lobar degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord. 2007;21:S31–S38
  12. Kimura N, Kumamoto T, Hanaoka T, Hazama Y, Nakamura K, Arakawa R. Corticobasal degeneration presenting with progressive conduction aphasia. J Neurol Sci. 2008;269:163–168
  13. Takao M, Tsuchiya K, Mimura M, Momoshima S, Kondo H, Akiyama H, et al. Corticobasal degeneration as a cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case. Neuropathology. 2006;26:569–578
  14. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129:1385–1398
  15. Grimes DA, Lang AE, Bergeron CB. Dementia as most common presentation of cortical-basal ganglionic degeneration. Neurology. 1999;53:1969–1974
  16. Murray R, Neumann M, Forman MS, Farmer J, Massimo L, Rice A, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology. 2007;68:1274–1283
  17. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53:795–800
  18. Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH. Is the pathology of corticobasal syndrome predictable in life?. published online Move Disord. 16 June 2009;
  19. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease- inclusion dementia presenting as cortico-basal ganglionic degeneration. Mov Disord. 1999;14:674–680
  20. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48:959–969
  21. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997;48:119–125
  22. Hu WT, Rippon GW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord. 2009;24:1375–1379
  23. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005;128:1247–1258
  24. Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, Petersen RC, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging. 2008;29:280–289

☆ The review of this paper was entirely handled by an Associate Editor, Robert Rodnitzky.

PII: S1353-8020(09)00303-4

doi: 10.1016/j.parkreldis.2009.11.013

Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 208-214 , March 2010

Article Tools

* Image Usage & Resolution